Abstract:Glycosylation is a tightly regulated post-translational modification where structured sugar groups are added to protein amino acid backbones, most commonly on asparagine for N-glycosylation. The glycosylation-regulating metabolic enzyme uridine diphosphate-glucose pyrophosphorylase 2 (UGP2) is required in oncogene-transformed cancer cells, but not in normal cells. UGP2 heavily regulates glycosylation of epidermal growth factor receptor (EGFR) at asparagine 361 (N361), a key site near the ligand binding domain. EGFR is a transmembrane tyrosine kinase receptor that promotes cell proliferation via growth cascades. Mutations and amplifications in EGFR account for a significant fraction of non-small cell lung carcinomas and breast adenocarcinoma, with L858R being the most common oncogenic hotspot. Other glycosylation sites on EGFR have been implicated in ligand binding, dimerization, and phosphorylation of downstream targets. Molecular dynamic simulations suggested that N361 may be important for dimerization or ligand binding. However, the functional relevance of how glycosylation of EGFR at N361 impacts EGFR protein and cellular behaviors remains unclear. To determine the functional relevance of glycosylation at N361, we created glycosylation-defective EGFR N361A mutant, with or without an additional oncogenic EGFR L858R mutant. We expressed these constructs in MCF10A and 293T cells, which do not have pre-existing activation of this pathway. Immunofluorescence and flow cytometry showed that the mutants were each well expressed at the cell membrane. Proximity ligation assays measuring dimerization of EGFR in cells showed that EGFR N361A greatly increased dimerization relative to wildtype controls. Loss of glycosylation of EGFR N361 impacted cell viability when grown in dose courses of its high affinity ligand EGF or lower affinity ligand amphiregulin. Furthermore, EGFR N361A desensitized cells expressing the oncogenic EGFR L858R to inhibitors targeting the extracellular domain, possibly because the mutation alters the antibody binding interface. N361A sensitized EGFR L858R to inhibitors targeting the cytoplasmic domain of EGFR. These findings help us understand the intricate relationship between EGFR and N-glycosylation, reinforcing the critical functional relevance of post-translational modifications on oncogenes. Citation Format: Dennis Lam, Ariel N. Liberchuk, Brandon Arroyo, Andrew L. Wolfe. Mechanistic effects of N361 glycosylation in epidermal growth factor receptor protein [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 4365.

Glycosylation at Asn254 Is Required for the Activation of the PDGF-C Protein

O-GlcNAcylation regulates epidermal growth factor receptor intracellular trafficking and signaling

N-glycosylation of the human neuropeptide QRFP receptor (QRFPR) is essential for ligand binding and receptor activation

Identification and Functional Characterization of Glycosylation of Recombinant Human Platelet- Derived Growth Factor-Bb in Pichia Pastoris

Functional effects of glycosylation at Asn-579 of the epidermal growth factor receptor

Glucose-mediated N-glycosylation of RPTPα Affects Its Subcellular Localization and Src Activation.

Platelet-derived Growth Factor-DD Targeting Arrests Pathological Angiogenesis by Modulating Glycogen Synthase Kinase-3β Phosphorylation*

N-glycosylation of α1D-adrenergic receptor N-terminal domain is required for correct trafficking, function, and biogenesis

Importance of N-linked Glycosylation in the Functional Expression of Murine CD1d1.

N-linked Glycosylation at Asn152 on CD147 Affects Protein Folding and Stability: Promoting Tumour Metastasis in Hepatocellular Carcinoma

Glycosylation limits forward trafficking of the tetraspan membrane protein PMP22

Effects of N361 Glycosylation on Epidermal Growth Factor Receptor Biological Function

The Platelet Surface Glycosylation Caused by Glycosidase Has a Strong Impact on Platelet Function

Differential Requirement of a Motif Within the Carboxyl-terminal Domain of Α-Platelet-derived Growth Factor (αpdgf) Receptor for PDGF Focus Forming Activity Chemotaxis, or Growth

Identification and Expression Analysis of an N-terminally Truncated Isoform of Human PDGF-C

Comprehensive Glycomic and Glycoproteomic Analyses of Human Programmed Cell Death Protein 1 Extracellular Domain

N-Glycosylation at Asn 402 Stabilizes N-Cadherin and Promotes Cell-Cell Adhesion of Glioma Cells

Atypical Protein Kinase Cλ Is Critical for Growth Factor Receptor-induced Dorsal Ruffle Turnover and Cell Migration

N-Glycosylation at Asn Residues 554 and 566 of E-Cadherin Affects Cell Cycle Progression Through Extracellular Signal-Regulated Protein Kinase Signaling Pathway

Abstract 4365: Mechanistic effects of N361 glycosylation in epidermal growth factor receptor protein

Different N-Glycosylation Sites Reduce the Activity of Recombinant DSPAα2